• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The alveolar-capillary membrane diffusing capacity and the pulmonary capillary blood volume in heart transplant candidates.心脏移植候选者的肺泡-毛细血管膜弥散能力和肺毛细血管血容量
Heart. 2000 Feb;83(2):156-60. doi: 10.1136/heart.83.2.156.
2
Mechanisms of pulmonary transfer factor decline following heart transplantation.
Eur J Cardiothorac Surg. 2000 Apr;17(4):355-61. doi: 10.1016/s1010-7940(00)00359-6.
3
Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance.慢性心力衰竭时肺泡-毛细血管膜扩散能力降低。其病理生理相关性及与运动能力的关系。
Circulation. 1995 Jun 1;91(11):2769-74. doi: 10.1161/01.cir.91.11.2769.
4
Lung membrane diffusing capacity, heart failure, and heart transplantation.肺膜弥散能力、心力衰竭与心脏移植
Am J Cardiol. 1999 Jan 1;83(1):62-7. doi: 10.1016/s0002-9149(98)00784-x.
5
[Pulmonary CO/NO transfer: physiological basis, technical aspects and clinical impact].[肺一氧化碳/一氧化氮转运:生理基础、技术层面及临床影响]
Rev Med Interne. 2014 May;35(5):322-7. doi: 10.1016/j.revmed.2013.11.001. Epub 2013 Dec 5.
6
Increased alveolar/capillary membrane resistance to gas transfer in patients with chronic heart failure.慢性心力衰竭患者肺泡/毛细血管膜对气体交换的阻力增加。
Br Heart J. 1994 Aug;72(2):140-4. doi: 10.1136/hrt.72.2.140.
7
Week to week variability of pulmonary capillary blood volume and alveolar membrane diffusing capacity in patients with heart failure.心力衰竭患者肺毛细血管血容量和肺泡膜弥散能力的周间变异性。
Respir Physiol Neurobiol. 2021 Aug;290:103679. doi: 10.1016/j.resp.2021.103679. Epub 2021 May 4.
8
Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane.血管紧张素转换酶抑制通过改善分子跨肺泡毛细血管膜的扩散,恢复慢性心力衰竭患者的一氧化碳弥散能力。
Clin Sci (Lond). 1999 Jan;96(1):17-22.
9
The TL,NO/TL,CO ratio in pulmonary function test interpretation.肺功能测试解读中的 TL、NO/TL、CO 比值。
Eur Respir J. 2013 Feb;41(2):453-61. doi: 10.1183/09031936.00082112. Epub 2012 Aug 30.
10
Alveolar-capillary membrane diffusion measurement by nitric oxide inhalation in heart failure.心力衰竭患者中通过吸入一氧化氮测量肺泡-毛细血管膜扩散
Eur J Prev Cardiol. 2015 Feb;22(2):206-12. doi: 10.1177/2047487313510397. Epub 2013 Oct 28.

本文引用的文献

1
STUDIES OF RESPIRATORY PHYSIOLOGY IN CHILDREN. VI. LUNG DIFFUSING CAPACITY, DIFFUSING CAPACITY OF THE PULMONARY MEMBRANE AND PULMONARY CAPILLARY BLOOD VOLUME IN CONGENITAL HEART DISEASE.儿童呼吸生理学研究。六、先天性心脏病患儿的肺弥散容量、肺膜弥散容量及肺毛细血管血容量
J Clin Invest. 1961 Aug;40(8 Pt 1-2):1431-41. doi: 10.1172/JCI104374.
2
SIGNIFICANCE OF CHANGES IN THE PULMONARY DIFFUSING CAPACITY IN MITRAL STENOSIS.二尖瓣狭窄时肺弥散能力改变的意义
Thorax. 1965 Mar;20(2):135-45. doi: 10.1136/thx.20.2.135.
3
Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries.扩散和化学反应速率在决定人体肺部气体交换速率中的相对重要性,特别提及肺膜的真正扩散能力和肺毛细血管中的血液量。
J Appl Physiol. 1957 Sep;11(2):290-302. doi: 10.1152/jappl.1957.11.2.290.
4
The measurement of the single-breath transfer factor for carbon monoxide and its components using the Morgan Transflow system.使用摩根跨流系统测量一氧化碳及其成分的单次呼吸转移因子。
Respir Med. 1998 Apr;92(4):628-32. doi: 10.1016/s0954-6111(98)90508-x.
5
The time course of pulmonary transfer factor changes following heart transplantation.心脏移植后肺转移因子变化的时间进程。
Eur J Cardiothorac Surg. 1997 Sep;12(3):471-8; discussion 478-9. doi: 10.1016/s1010-7940(97)00127-9.
6
Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.肺容量与用力通气流量。欧洲煤钢共同体肺功能测试标准化工作小组报告。欧洲呼吸学会官方声明。
Eur Respir J Suppl. 1993 Mar;16:5-40.
7
Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.转移因子(弥散能力)测量的标准化。肺功能测试标准化工作组报告,欧洲煤钢共同体。欧洲呼吸学会官方声明。
Eur Respir J Suppl. 1993 Mar;16:41-52.
8
Diffusing capacity decreases after heart transplantation.
Chest. 1993 Mar;103(3):857-61. doi: 10.1378/chest.103.3.857.
9
Pulmonary function after successful heart transplantation. One year follow-up.心脏移植成功后的肺功能。一年随访。
Chest. 1993 Jan;103(1):54-8. doi: 10.1378/chest.103.1.54.
10
Respiratory dysfunction in congestive heart failure: correction after heart transplantation.
Eur Respir J. 1993 Sep;6(8):1197-201.

心脏移植候选者的肺泡-毛细血管膜弥散能力和肺毛细血管血容量

The alveolar-capillary membrane diffusing capacity and the pulmonary capillary blood volume in heart transplant candidates.

作者信息

Al-Rawas O A, Carter R, Stevenson R D, Naik S K, Wheatley D J

机构信息

Department of Respiratory Medicine, Glasgow Royal Infirmary, Glasgow G31 2ES, UK.

出版信息

Heart. 2000 Feb;83(2):156-60. doi: 10.1136/heart.83.2.156.

DOI:10.1136/heart.83.2.156
PMID:10648487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1729318/
Abstract

OBJECTIVES

To determine the mechanism of impairment of pulmonary transfer factor for carbon monoxide (TL(CO)) in heart transplant candidates, as this is the most common lung function abnormality.

SETTING

Regional cardiopulmonary transplant centre.

METHODS

TL(CO) and its components (the diffusing capacity of the alveolar-capillary membrane (D(M)) and the pulmonary capillary blood volume (V(C))) were measured using the Roughton and Forster method and the single breath technique in 38 patients with severe chronic heart failure awaiting heart transplantation (mean age 51 years, range 19 to 61; mean left ventricular ejection fraction 12.8%). Results were compared with data from 26 normal subjects (mean age 47 years, range 27 to 62).

RESULTS

Mean per cent predicted TL(CO), D(M), and V(C) were significantly reduced in patients (69.9%, 81.4%, and 80.2% of predicted, respectively) compared with controls (97.7%, 100.1%, and 102.3% of predicted, respectively, p < 0.001). The relative contribution of the two components of TL(CO) in patients was similar to that of normal subjects, with each component accounting for approximately 50% of the total resistance to diffusion (1/TL(CO)).

CONCLUSIONS

TL(CO) impairment in patients with severe chronic heart failure awaiting heart transplantation results from a proportionate reduction in both D(M) and V(C), suggesting a significant disturbance of the pulmonary vascular bed.

摘要

目的

确定等待心脏移植者一氧化碳肺转移因子(TL(CO))受损的机制,因为这是最常见的肺功能异常。

地点

地区心肺移植中心。

方法

采用Roughton和Forster方法及单次呼吸技术,对38例等待心脏移植的严重慢性心力衰竭患者(平均年龄51岁,范围19至61岁;平均左心室射血分数12.8%)测量TL(CO)及其组成部分(肺泡-毛细血管膜弥散量(D(M))和肺毛细血管血容量(V(C)))。将结果与26名正常受试者(平均年龄47岁,范围27至62岁)的数据进行比较。

结果

与对照组相比,患者的平均预计TL(CO)、D(M)和V(C)显著降低(分别为预计值的69.9%、81.4%和80.2%),而对照组分别为预计值的97.7%、100.1%和102.3%(p<0.001)。患者中TL(CO)两个组成部分的相对贡献与正常受试者相似,每个组成部分约占总扩散阻力(1/TL(CO))的50%。

结论

等待心脏移植的严重慢性心力衰竭患者的TL(CO)受损是由于D(M)和V(C)均成比例降低,提示肺血管床存在明显紊乱。